» Articles » PMID: 21750166

Magnesium Reduces Calcification in Bovine Vascular Smooth Muscle Cells in a Dose-dependent Manner

Overview
Date 2011 Jul 14
PMID 21750166
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Vascular calcification (VC), mainly due to elevated phosphate levels, is one major problem in patients suffering from chronic kidney disease. In clinical studies, an inverse relationship between serum magnesium and VC has been reported. However, there is only few information about the influence of magnesium on calcification on a cellular level available. Therefore, we investigated the effect of magnesium on calcification induced by β-glycerophosphate (BGP) in bovine vascular smooth muscle cells (BVSMCs).

Methods: BVSMCs were incubated with calcification media for 14 days while simultaneously increasing the magnesium concentration. Calcium deposition, transdifferentiation of cells and apoptosis were measured applying quantification of calcium, von Kossa and Alizarin red staining, real-time reverse transcription-polymerase chain reaction and annexin V staining, respectively.

Results: Calcium deposition in the cells dramatically increased with addition of BGP and could be mostly prevented by co-incubation with magnesium. Higher magnesium levels led to inhibition of BGP-induced alkaline phosphatase activity as well as to a decreased expression of genes associated with the process of transdifferentiation of BVSMCs into osteoblast-like cells. Furthermore, estimated calcium entry into the cells decreased with increasing magnesium concentrations in the media. In addition, higher magnesium concentrations prevented cell damage (apoptosis) induced by BGP as well as progression of already established calcification.

Conclusions: Higher magnesium levels prevented BVSMC calcification, inhibited expression of osteogenic proteins, apoptosis and further progression of already established calcification. Thus, magnesium is influencing molecular processes associated with VC and may have the potential to play a role for VC also in clinical situations.

Citing Articles

Lower serum magnesium levels are associated with a higher risk of fractures and vascular calcifications in hemodialysis patients.

Matias P, Avila G, Domingos D, Gil C, Ferreira A Clin Kidney J. 2025; 18(1):sfae381.

PMID: 40008355 PMC: 11852323. DOI: 10.1093/ckj/sfae381.


Beyond Numbers: How Biochemical Parameters Can Predict Outcomes in Chronic Kidney Disease Patients on Maintenance Hemodialysis.

Siddiqui I, Masood A, Chandagiri S, Kumar R, Mir A Cureus. 2024; 16(8):e67349.

PMID: 39310569 PMC: 11413472. DOI: 10.7759/cureus.67349.


Unraveling the Mechanisms of Magnesium Supplementation in Alleviating Chronic Kidney Disease Complications and Progression: Balancing Risks and Benefits.

Sadeghpour M, Bejani A, Hosseini Kupaei M, Majd S, Najafi A, Fakhari S Biol Trace Elem Res. 2024; .

PMID: 39256329 DOI: 10.1007/s12011-024-04368-1.


Role of Magnesium, Effects of Hypomagnesemia, and Benefits of Magnesium Supplements in Cardiovascular and Chronic Kidney Diseases.

Panta R, Regmi S Cureus. 2024; 16(7):e64404.

PMID: 39130977 PMC: 11317063. DOI: 10.7759/cureus.64404.


Inquiry of the Metabolic Traits in Relationship with Daily Magnesium Intake: Focus on Type 2 Diabetic Population.

Gheorghe A, Ciobica M, Nistor C, Gurzun M, Sandulescu B, Stanciu M Clin Pract. 2024; 14(4):1319-1347.

PMID: 39051301 PMC: 11270223. DOI: 10.3390/clinpract14040107.


References
1.
Covic A, Kanbay M, Voroneanu L, Turgut F, Serban D, Serban I . Vascular calcification in chronic kidney disease. Clin Sci (Lond). 2010; 119(3):111-21. DOI: 10.1042/CS20090631. View

2.
Wallin R, Cain D, Hutson S, Sane D, Loeser R . Modulation of the binding of matrix Gla protein (MGP) to bone morphogenetic protein-2 (BMP-2). Thromb Haemost. 2001; 84(6):1039-44. View

3.
Planells E, Llopis J, Peran F, Aranda P . Changes in tissue calcium and phosphorus content and plasma concentrations of parathyroid hormone and calcitonin after long-term magnesium deficiency in rats. J Am Coll Nutr. 1995; 14(3):292-8. DOI: 10.1080/07315724.1995.10718510. View

4.
Montezano A, Zimmerman D, Yusuf H, Burger D, Chignalia A, Wadhera V . Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium. Hypertension. 2010; 56(3):453-62. DOI: 10.1161/HYPERTENSIONAHA.110.152058. View

5.
Turgut F, Kanbay M, Metin M, Uz E, Akcay A, Covic A . Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis. Int Urol Nephrol. 2008; 40(4):1075-82. DOI: 10.1007/s11255-008-9410-3. View